Overview

OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis

Status:
Unknown status

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

A randomised, prospective, cross over study will be done to determine whether the anticoagulation therapy with UFH or LMWH used for hemodialysis sessions modifies osteoprotegerin and RANKL plasma levels.

Phase:

N/A

Details

Lead Sponsor:

IRCCS Azienda Ospedaliero-Universitaria di Bologna
St. Orsola Hospital

Treatments:

Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Nadroparin